Vivante Health, a digital gastrointestinal health company, has successfully closed a $31 million Series B funding round. The round was led by new investor Mercato Partners, and the total funds raised by Vivante Health now amount to $47 million. Other participants in the funding round included Health Catalyst Capital, Intermountain Ventures, SemperVirens, 7wireVentures, Human Capital, and Distributed Ventures.
Key Highlights:
- GIThrive Platform: Vivante offers a platform named GIThrive, which delivers personalized care plans for patients. Through this platform, patients can monitor their symptoms, access educational materials, and utilize self-guided behavioral health modules. Additionally, the platform connects patients with a coordinated team of professionals, such as dietitians, coaches, and health physicians.
- Use of Funds: The Illinois-based company plans to utilize the new investment to enhance its technology and grow its workforce.
- CEO’s Statement: Bill Snyder, the CEO of Vivante Health, expressed his excitement about the support from leading capital partners. He emphasized the company’s mission to address the digestive disorders and symptoms affecting one in four Americans, aiming to improve their quality of life and reduce healthcare costs.
- Previous Funding: Vivante Health had previously secured $16 million in Series A funding in the last year, $5.8 million in Series A1 investment in 2020, and $6 million in 2018.
- Collaborations: In 2022, Solera Health integrated Vivante and another digital gastrointestinal health company, Oshi Health, into its marketplace of benefits and chronic care management tools.